1 |
World Health Organization (WHO). 1994. Assessment of fracture risk and its application to screening for post-menopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 843, 1-129.
|
2 |
Wuttke, W., Seidlova-Wuttke, D. and Gorkow, C. 2003. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 44, S67-S77.
DOI
|
3 |
Yang, Q., Populo, S. M., Zhang, J., Yang, G. and Kodama,H. 2002. Effect of Angelica sinensis on the proliferation of human bone cells. Clinica Chimica Acta 324, 89-97.
DOI
|
4 |
Yin, J., Tezuka, Y., Subehan, Shi, L., Nobukawa, M., Nobukawa, T. and Kadota, S. 2006. In vivo anti-osteoporotic activity of isotaxiresinol, a lignan from wood of Taxus yunnanensis. Phytomedicine 13, 37-42.
DOI
|
5 |
Zhang, Y., Leung, P. C., Che, C. T., Chow, H. K., Wu, C.F. and Wong, M. S. 2008. Improvement of bone properties and enhancement of mineralization by ethanol extract of fructus Ligustri lucidi. Br. J. Nutr. 99, 494-502.
|
6 |
Teitelbaum, S. L. 2000. Bone resorption by osteoclasts. Science 289, 1504-1508.
DOI
ScienceOn
|
7 |
Song, K. B., Atkinson, C., Frankenfeld, C. L., Jokela, T.,Wahala, K., Thomas, W. K. and Lampe, J. W. 2006. Prevalence of daidzein-metabolizing phenotypes differs between Caucasian and Korean American women and girls. J. Nutr. 136, 1347-1351.
DOI
|
8 |
Song, L., Zhao, J., Zhang, X., Li, H. and Zhou, Y. 2013. Icariin induces osteoblast proliferation, differentiation and mineralization through estrogen receptor-mediated ERK and JNK signal activation. Eur. J. Pharmacol. 714, 15-22.
DOI
|
9 |
Subbiah, V., Madsen, V. S., Raymond, A. K., Benjamin, R.S. and Ludwig, J. A. 2010. Of mice and men: divergent risks of teriparatide-induced osteosarcoma. Osteoporos Int. 21, 1041- 1045.
DOI
|
10 |
Wang, P. P., Zhu, X. F., Yang, L., Liang, H., Feng, S. W. and Zhang, R. H. 2012. Puerarin stimulates osteoblasts differentiation and bone formation through estrogen receptor, p38 MAPK, and Wnt/β-catenin pathways. J. Asian Nat. Prod. Res. 14, 897-905.
DOI
|
11 |
Wetli, H. A., Brenneisen, R., Tschudi, I., Langos, M., Bigler,P., Sprang, T., Schürch, S. and Mühlauer, R. C. 2005. A gamma-glutamyl peptide isolated from onion (Allium cepa L.)by bioassay guided fractionation inhibits resorption activity of osteoclasts. J. Agric. Food Chem. 53, 3408-3414
DOI
|
12 |
Whelan, A. M., Jurgen, T. M., Bowles, S. K. and Doyle, H. 2009. Efficacy of natural health products in treating osteoporosis: what is the quality of internet patient advice?. Ann. Pharmacother. 43, 899-907.
DOI
|
13 |
Woo, S., Hellstein, J. and Kalmar, J. 2006. Narrative review: biphosphates and osteonecrosis of the jaws. Ann. Intern. Med. 144, 753-761.
DOI
|
14 |
Saag, K. G., Shane, E., Boonen, S., Marin, F., Dongley, D.W., Taylor, K. A., Dalsky, G. P. and Marcus, R. 2007. Teriparatideor alendronate in glucocorticoid-induced osteoporosis. N. Engl. J. Med. 357, 2028-2039
DOI
|
15 |
Raisz, L. G. 2005. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J. Clin. Invest. 115, 3318-3325.
DOI
|
16 |
Rodan, G. A. and Martin, T. J. 2000. Therapeutic approaches to bone diseases. Science 289, 1508-1514.
DOI
|
17 |
Rodan, G. A., Raisz, L. G. and Bilezikian, J. P. 2002. Pathophysiology of osteoporosis. Principles of Bone Biology San Diego: Academic Press.
|
18 |
Sethi, G. and Aggarwal, B. B. 2007. Mending the bones with natural products. Chem. Biol. 14, 738-740.
DOI
|
19 |
Santiago-Mora, R., Casado-Díaz, A., De Castro, M. D. and Quesada-Gómez, J. M. 2011. Oleuropein enhances osteo-blastogenesis and inhibits adipogenesis: the effect on differentiation in stem cells derived from bone marrow. Osteoporos Int. 22, 675-684.
DOI
ScienceOn
|
20 |
Setchell, K. D. R., Brown, N. M. and Lydeking-Olsen, E. 2002. The clinical importance of the metabolite equol - aclue to the effectiveness of soy and its isoflavones. J. Nutr. 132, 3577-3684.
DOI
|
21 |
Shishodia, S., Sethi, G. and Aggarwal, B. B. 2005. Curcumin:getting back to the roots. Ann N Y Acad Sci 1056, 206-217.
DOI
|
22 |
Somjen, D. and Yoles, I. 2003. DT56a (Tofupill/Femarelle) selectively stimulates creatine kinase specific activity in skeletal tissues of rats but not in the uterus. J. Steroid Biochem.Mol. Biol. 86, 93-98.
DOI
|
23 |
Muhlbauer, R. C., Lozano, A., Palacio, S., Reinli, A. and Felix, R. 2003. Common herbs, essential oils, and monoterpenes potently modulate bone metabolism. Bone 32, 372-380.
DOI
|
24 |
Li, J. X., Liu, J., He, C. C., Yu, Z. Y., Du, Y., Kadota, S. and Seto, H. 2007. Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss. Maturitas 58, 59-69.
DOI
ScienceOn
|
25 |
Li, N., Jiang, Y., Wooley, P. H., Xu, Z. and Yang, S. Y. 2013. Naringin promotes osteoblast differentiation and effectively reverses ovariectomy-associated osteoporosis. J. Orthop. Sci. 18, 478-485.
DOI
|
26 |
Messina, M. 2010. A brief historical overview of the past two decades of soy and isoflavone research. J. Nutr. 140, 1350-1354.
DOI
|
27 |
Pan, W., Quarles, L. D., Song, L. H., Yu, Y. H., Jiao, C.,Tang, H. B., Jiang, C. H., Deng, H. W., Li, Y. J., Zhou, H.H. and Xiao, Z. S. 2005. Genistein stimulates the osteoblastic differentiation via NO/cGMP in bone marrow culture. J. Cell Biochem. 94, 307-316.
DOI
|
28 |
Nakagawa, H., Wachi, M., Woo, J. T., Kato, M., Kasai, S., Takahashi, F., Lee, I. S. and Nagai, K. 2002. Fenton reaction is primarily involved in a mechanism of (-)-epigallocatechin-3-gallate to induce osteoclastic cell death. Biochem. Biophys. Res. Commun. 292, 94-101
DOI
|
29 |
National Osteoporosis Foundation. 2010. Clinician’s guide to prevention and treatment of osteoporosis. Washington, DC. National Osteoporosis Foundation.
|
30 |
Ott, S. M. 2005. Long-term safety of biphosphonates. J. Clin. Endocrinol. Metab. 90, 1897-1899.
DOI
|
31 |
Khosla, S. 2001. Minireview: The OPG/RANKL/RANK system. Endocrinology 142, 5050-5055.
DOI
|
32 |
Putnam, S. E., Scutt, A. M., Bicknell, K., Priestley, C. M.and Williamson, E. M. 2007. Natural products as alternative treatments for metabolic bone disorders and for maintenance of bone health. Phytother. Res. 21, 99-112.
DOI
|
33 |
Hsu, C. H. and Cheng, A. L. 2007. Clinical studies with curcumin. Adv. Exp. Med. Biol. 595, 471-480.
DOI
|
34 |
Jeong, J. C., Lee, J. W., Yoon, C. H., Lee, Y. C., Chung, K. H., Kim, M. G. and Kim, C. H. 2005. Stimulative effects of Drynariae Rhizoma extracts on the proliferation and differentiation of osteoblastic MC3T3-E1 cells. J. Ethnopharmacol. 96, 489-495.37.
DOI
|
35 |
Li, F., Sun, X., Ma, J., Ma, X., Zhao, B., Zhang, Y., Tian, P.,Li, Y. and Han, Z. 2014. Naringin prevents ovariectomy-induce dosteoporosis and promotes osteoclasts apoptosis through the mitochondria-mediated apoptosis pathway. Biochem. Biophys. Res. Commun. 452, 629-635.
DOI
|
36 |
Kim, K. W., Suh, S. J., Lee, T. K., Ha, K. T., Kim, J. K., Kim,K. H., Kim, D. I., Jeon, J. H., Moon, T. C. and Kim, C. H. 2008. Effect of safflower seeds supplementation on stimulation of the proliferation, differentiation and mineralization osteoblastic MC3T3-E1 cells. J. Ethnopharmacol. 115, 42-49.
DOI
|
37 |
Kohrt, W. M., Snead, D. B., Slatopolsky, E. and Birge, S. J. 1995. Additive effects of weight-bearing exercise and estrogenon bone mineral density in older women. J. BoneMiner. Res. 10, 1303-1311.
|
38 |
Lee, S. U., Park, S. J., Kwak, H. B., Oh, J., Min, Y. K. and Kim, S. H. 2008. Anabolic activity of ursolic acid in bone: stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo. Pharmacol. Res. 58, 290-296.
DOI
|
39 |
Cornish, J., Callon, K. E., Naot, D., Palmano, K. P., Banovic,T., Bava, U., Watson, M., Lin, J., Tong, P. C., Chen, Q., Chan,V. A ., Haggarty, N. W., Grey, A. B. and Reid, I. R. 2004. Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145, 4366-4374.
DOI
|
40 |
Li, F., Yang, Y., Zhu, P., Chen, W., Qi, D., Shi, X., Zhang, C., Yang, Z. and Li, P. 2012. Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells. Fitoterapia 83, 1443-1450.
DOI
|
41 |
Cassidy, A., Albertazzi, P., Nielsen, I. L., Hall, W.,Williamson, G., Tetens, I., Atkins, S., Cross, H., Manios, Y.,Wolk, A., Steiner, C. and Branca, F. 2006. Critical review of health effects of soyabean phyto-oestrogens in post-men-opausal women. Proc. Nutr. Soc. 65, 76-92.
DOI
|
42 |
Fonseca, D. and Ward, W. E. 2004. Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone 35, 489-497.
DOI
|
43 |
Chen, C. H., Ho, M. L., Chang, J. K., Hung, S. H. and Wang, G. J. 2005. Green tea catech in enhances osteogenesis in a bone marrow mesenchymal stem cell line. Osteoporos Int. 16, 2039-2045.
DOI
|
44 |
Cotter, A. and Cashman, K. D. 2003. Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy. Nutr. Rev. 61, 346-351.
DOI
|
45 |
Devareddy, L., Khalil, D. A., Korlagunta, K., Hooshmand,S., Bellmer, D. D. and Arjmandi, B. H. 2006. The effects of fructooligosaccharides in combination with soy protein on bone in osteopenic ovariectomized rats. Menopause 13,692-699.
DOI
|
46 |
Frankenfeld, C. L., Atkinson, C., Thomas, W. K., Gonzalez,A., Jokela, T., Wahala, K., Schwartz, S. M., Li, S. S. and Lampe, J. W. 2005. High concordance of daidzein-metabolizing phenotypes in individuals measured 1 to 3 years apart.Br. J. Nutr. 94, 873-876.
DOI
|
47 |
Hill, P. A. 1998. Bone Remodeling. Br. J. Orthod. 25, 101-107.
DOI
|
48 |
Bharti, A. C., Takada, Y. and Aggarwa, B. B. 2004. Curcumin (diferulolylmethane) inhibits receptor activator of NF-κ B ligand-induced NF-κ B activation in osteoclast precursors and suppresses osteoclastogenesis. J. Immunol. 172, 5940-5947.
DOI
|
49 |
Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., Mautalen, C., Mesenbrink, P., Hu, H., Caminis, J., Tong, K., Rosario-Jansen, T., Krasnow, J., Hue, T. F., Sellmeyer, D., Eriksen, E. F. and Cummings, S. R. 2007. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.N. Engl. J. Med. 356, 1809-1822.
DOI
|
50 |
Branca, F. 2003. Dietary phyto-oestrogens and bone health.Proc. Nutr. Soc. 62, 877-887.
DOI
|
51 |
Brenneman, S. K., Barrett-Connor, E. S., Sajjan, L. E., Markson and Siris, E. S. 2006. Impact of recent fracture on health-related quality of life in postmenopausal women. J. Bone Miner. Res. 21, 809-816.
DOI
|
52 |
Brouns, F. and Vermeer, C. 2000. Functional food ingredients for reducing the risks of osteoporosis. Trends Food Sci. Technol. 11, 22-33.
DOI
|